Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
News

Worries About Gibson Film Escalate

A forthcoming Mel Gibson movie about Jesus’ last hours of life is the focus of escalating concern among Jewish groups, which are stepping up their statements expressing worries that the project could revive dangerous notions of Jewish responsibility for Jesus’ death.

Citing a report on a draft of the film’s script by an embattled group of Catholic and Jewish scholars, the Anti-Defamation League said last week that it has “serious concerns” about Gibson’s movie, “The Passion.” It praised the 18-page report prepared by the ad hoc group of nine scholars, who, the ADL said, “unanimously agreed that the screenplay reviewed was replete with objectionable elements that would promote antisemitism.”

Gibson, for his part, has insisted that “neither I nor my film is antisemitic,” and his production company has lashed out at the scholars, insisting that the script they reviewed is outdated.

For a full report on the situation, please visit the Forward online at www.forward.com.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.